Explore more publications!
Healthcare Today Michigan
Got News to Share?

Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 15, 2025

Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
October 15, 2025

Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

Indeterminate GlobeNewswire
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
October 15, 2025

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Indeterminate GlobeNewswire
SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio
October 15, 2025

SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio

Indeterminate GlobeNewswire
Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers
October 15, 2025

Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers

Indeterminate GlobeNewswire
Amphista Therapeutics nominates AMX-883, an orally available Targeted Glue™ degrader of BRD9, as its first clinical development candidate for the treatment of acute myeloid leukaemia
October 15, 2025

Amphista Therapeutics nominates AMX-883, an orally available Targeted Glue™ degrader of BRD9, as its first clinical development candidate for the treatment of acute myeloid leukaemia

Indeterminate GlobeNewswire
Verano Announces Grand Opening of Zen Leaf Antwerp in 19th Century Historic Ohio Train Depot, Offering Cannabis Consumers One of the Most Unique Dispensary Shopping Experiences in the U.S.
October 15, 2025

Verano Announces Grand Opening of Zen Leaf Antwerp in 19th Century Historic Ohio Train Depot, Offering Cannabis Consumers One of the Most Unique Dispensary Shopping Experiences in the U.S.

Indeterminate GlobeNewswire
Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platform
October 15, 2025

Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platform

Indeterminate GlobeNewswire
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis
October 15, 2025

Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis

Indeterminate GlobeNewswire
Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital
October 15, 2025

Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital

Indeterminate GlobeNewswire
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
October 15, 2025

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

Indeterminate GlobeNewswire
Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund
October 15, 2025

Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund

Indeterminate GlobeNewswire
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
October 15, 2025

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Indeterminate GlobeNewswire
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
October 15, 2025

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Indeterminate GlobeNewswire
Vara erhält CE-Zertifizierung als einzige KI für eine unabhängige Zweitbefundung in der Mammographie und expandiert in Europa
October 15, 2025

Vara erhält CE-Zertifizierung als einzige KI für eine unabhängige Zweitbefundung in der Mammographie und expandiert in Europa

Indeterminate GlobeNewswire
EyePoint Announces Pricing of Public Offering
October 15, 2025

EyePoint Announces Pricing of Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions